Heo Y[au] - Search Results

Year	Number of Results
1987	1
1990	1
1994	1
1996	1
1997	2
1998	2
1999	1
2000	1
2001	5
2002	10
2003	8
2004	11
2005	15
2006	11
2007	11
2008	24
2009	34
2010	49
2011	43
2012	35
2013	48
2014	53
2015	59
2016	67
2017	64
2018	73
2019	86
2020	101
2021	119
2022	93

1

Heo YA. Heo YA. Drugs. 2022 Feb;82(3):341-348. doi: 10.1007/s40265-022-01678-3. Drugs. 2022. PMID: 35179720 Free PMC article. Review.

2

Budesonide/Glycopyrronium/Formoterol: A Review in COPD.

Heo YA. Heo YA. Drugs. 2021 Aug;81(12):1411-1422. doi: 10.1007/s40265-021-01562-6. Epub 2021 Aug 3. Drugs. 2021. PMID: 34342835 Free PMC article. Review.

3

Imipenem/Cilastatin/Relebactam: A Review in Gram-Negative Bacterial Infections.

Heo YA. Heo YA. Drugs. 2021 Feb;81(3):377-388. doi: 10.1007/s40265-021-01471-8. Epub 2021 Feb 25. Drugs. 2021. PMID: 33630278 Free PMC article. Review.

4

A Variant of SLC1A5 Is a Mitochondrial Glutamine Transporter for Metabolic Reprogramming in Cancer Cells.

Yoo HC, Park SJ, Nam M, Kang J, Kim K, Yeo JH, Kim JK, Heo Y, Lee HS, Lee MY, Lee CW, Kang JS, Kim YH, Lee J, Choi J, Hwang GS, Bang S, Han JM. Yoo HC, et al. Among authors: heo y. Cell Metab. 2020 Feb 4;31(2):267-283.e12. doi: 10.1016/j.cmet.2019.11.020. Epub 2019 Dec 19. Cell Metab. 2020. PMID: 31866442 Free article.

5

Voclosporin: First Approval.

Heo YA. Heo YA. Drugs. 2021 Apr;81(5):605-610. doi: 10.1007/s40265-021-01488-z. Drugs. 2021. PMID: 33788181 Free PMC article. Review.

6

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia.

Heo YA, Syed YY, Keam SJ. Heo YA, et al. Drugs. 2019 May;79(7):767-777. doi: 10.1007/s40265-019-01120-1. Drugs. 2019. PMID: 31030380 Free PMC article. Review.

7

Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer.

Kim R, An M, Lee H, Mehta A, Heo YJ, Kim KM, Lee SY, Moon J, Kim ST, Min BH, Kim TJ, Rha SY, Kang WK, Park WY, Klempner SJ, Lee J. Kim R, et al. Among authors: heo yj. Cancer Discov. 2022 Apr 1;12(4):984-1001. doi: 10.1158/2159-8290.CD-21-0888. Cancer Discov. 2022. PMID: 34933901

8

Sotrovimab: First Approval.

Heo YA. Heo YA. Drugs. 2022 Mar;82(4):477-484. doi: 10.1007/s40265-022-01690-7. Drugs. 2022. PMID: 35286623 Free PMC article. Review.

9

TFEB-GDF15 axis protects against obesity and insulin resistance as a lysosomal stress response.

Kim J, Kim SH, Kang H, Lee S, Park SY, Cho Y, Lim YM, Ahn JW, Kim YH, Chung S, Choi CS, Jang YJ, Park HS, Heo Y, Kim KH, Lee MS. Kim J, et al. Among authors: heo y. Nat Metab. 2021 Mar;3(3):410-427. doi: 10.1038/s42255-021-00368-w. Epub 2021 Mar 22. Nat Metab. 2021. PMID: 33758420

10

Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology.

Lee HT, Lee SH, Heo YS. Lee HT, et al. Among authors: heo ys. Molecules. 2019 Mar 26;24(6):1190. doi: 10.3390/molecules24061190. Molecules. 2019. PMID: 30917623 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results